October 2, 2020
The U.S. Attorney’s Office for the District of Massachusetts logged another victory in its battle against co-pay foundation kickback schemes. This time pharma giant Gilead Sciences is paying up to the tune of $97 million. The government alleged that Gilead illegally used a non-profit foundation as a conduit to pay the Medicare co-pays for its own drug.
We have previously detailed why this is illegal. We have also reported on two ongoing cases against Regeneron and Teva Pharmaceuticals.
As reported in the government’s press release:
To date, the Department of Justice has collected over $1 billion from eleven pharmaceutical companies (United Therapeutics, Pfizer, Actelion, Jazz, Lundbeck, Alexion, Astellas, Amgen, Sanofi, Novartis, and Gilead) that allegedly used third-party foundations as kickback vehicles. The Department also has reached settlements with four foundations (Patient Access Network Foundation, Chronic Disease Fund, The Assistance Fund, and Patient Services, Inc.) and a pharmacy (Advanced Care Scripts, Inc.) that allegedly conspired or coordinated with pharmaceutical companies on these kickback schemes.
The government has been resolute in its commitment to rooting out this type of fraud and will no doubt continue to pursue such actions in and out of court.
Apr 16, 2011
As part of the 1986 amendments to the federal False Claims Act (FCA), Congress added a new liability provision. See 31 U.S.C. § 3729(a)(1), now codified as amended at §...Jul 7, 2020
Medicaid cannot negotiate drug prices the way private insurers can. This creates a risk that the public will overpay for needed drugs. The Medicaid Drug Rebate Program requires manufacturers to...Apr 1, 2019
How does the False Claims Act bootstrap other theories of liability and turn into civil damages, violations of other statutes, including criminal laws? As Bob Thomas’ Health Care Fraud and...